(Q34982550)

5 August 2017

Sedation and antihistamines: a review of inter-drug differences using proportional impairment ratios (English)

1 reference

5 August 2017

1 reference

Z Shamsi

1

1 reference

PubMed ID

12404608

5 August 2017

I Hindmarch

series ordinal

2

1 reference

5 August 2017

1 October 2000

1 reference

5 August 2017

Human Psychopharmacology

1 reference

5 August 2017

15

1 reference

5 August 2017

S1

1 reference

5 August 2017

S3-S30

1 reference

Rational use of antihistamines in allergic dermatological conditions

5 August 2017

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Selective displacement of [3H]mepyramine from peripheral vs. central nervous system receptors by loratadine, a non-sedating antihistamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

A retrospective study of promethazine and its failure to produce the expected incidence of sedation during space flight

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

The effect of diphenhydramine alone and in combination with ethanol on histamine skin response and mental performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

The effects of terfenadine with and without alcohol on an aspect of car driving performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Effects of azatadine maleate on subjective appraisal and psychomotor functions relevant to driving performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Visual motor co-ordination and dynamic visual acuity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Studies on the central effects of the H1-antagonist, loratadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Evidence for tolerance to the central nervous effects of the histamine antagonist, triprolidine, in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Effects on the human central nervous system of two isomers of ephedrine and triprolidine, and their interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Correlation between plasma diphenhydramine level and sedative and antihistamine effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Performance studies with antihistamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

The acute effects of acrivastine (BW825C), a new antihistamine, compared with triprolidine on measures of central nervous system performance and subjective effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

The effects of acrivastine (BW825C), diphenhydramine and terfenadine in combination with alcohol on human CNS performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Onset of action and efficacy of terfenadine, astemizole, cetirizine, and loratadine for the relief of symptoms of allergic rhinitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Second-generation antihistamines: the risk of ventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

CNS Effects of the Antihistamines Diphenhydramine and Terfenadine (RMI 9918)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

The influence of antihistamines on human performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

The relative antihistaminic and psychomotor effects of hydroxyzine and cetirizine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

The pharmacodynamics of diphenhydramine-induced drowsiness and changes in mental performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

A comparison of triprolidine and cyclizine on histamine (H1) antagonism, subjective effects and performance tests in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Loratadine. A reappraisal of its pharmacological properties and therapeutic use in allergic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

The effects of the sub-chronic administration of an anti-histamine, clemastine, on tests of car driving ability and psychomotor performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Psychomotor function and psychoactive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Psychometric aspects of antihistamines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Antihistamines: models to assess sedative properties, assessment of sedation, safety and other side-effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Placebo controlled comparison of acute effects of ebastine and clemastine on performance and EEG

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

COMPARATIVE EFFECT OF THREE ANTIHISTAMINICS AND ETHANOL ON MENTAL AND MOTOR PERFORMANCE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Loratadine: a non-sedating antihistamine. Review of its effects on cognition, psychomotor performance, mood and sedation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

The psychomotor and cognitive effects of a new antihistamine, mizolastine, compared to terfenadine, triprolidine and placebo in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Some clinical pharmacological studies with terfenadine, a new antihistamine drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

The Effect of Nitrazepam on Manual Skill, Grip Strength, and Reaction Time with Special Reference to Subjective Evaluation of Effects on Sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Peripheral antihistamine and central sedative effects of three H1-receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Assessment of drugs' side effects: Visual Analogue Scale versus check-list format.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Diazepam effects on the performance of healthy subjects are not enhanced by treatment with the antihistamine ebastine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Acute and subacute actions on human performance and interactions with diazepam of temelastine (SK&F93944) and diphenhydramine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Terfenadine. An updated review of its pharmacological properties and therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Differences in performance impairment due to brompheniramine maleate as a function of the sustained-release system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Effects of terfenadine and diphenhydramine alone or in combination with diazepam or alcohol on psychomotor performance and subjective feelings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Evaluation of antihistamine-related daytime sleepiness. A double-blind, placebo-controlled study with terfenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Effect of the antihistamines, brompheniramine maleate and triprolidine hydrochloride, on performance in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Antihistamines and visual function: studies on dynamic acuity and the pupillary response to light

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Performance studies with the H1-histamine receptor antagonists, astemizole and terfenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Antihistamines: impaired performance and the tendency to sleep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989-94.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Promethazine, scopolamine and cinnarizine: comparative time course of psychological performance effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Lack of interaction between two antihistamines, mizolastine and cetirizine, and ethanol in psychomotor and driving performance in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Acrivastine, terfenadine and diphenhydramine effects on driving performance as a function of dose and time after dosing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Cetirizine and loratadine: a comparison using the ED50 in skin reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Chronopharmacological study of antihistamines in man with special references to terfenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Astemizole. A review of its pharmacodynamic properties and therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

The clinical efficacy of H1 antagonists in urticaria and rhinitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Lack of behavioural toxicity of mizolastine: a review of the clinical pharmacology studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Sedative effects of antihistamines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Pharmacokinetics and pharmacodynamics of diphenhydramine 25 mg in young and elderly volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Sleepiness and performance during three-day administration of cetirizine or diphenhydramine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Single and repeated dose comparison of three antihistamines and phenylpropanolamine: psychomotor performance and subjective appraisals of sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

A new classification of H1-receptor antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

The eternal triangle: benefit, risk, and cost of therapeutic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

H1-receptor antagonists: safety issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Central nervous system effects of H1-receptor antagonists in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Pharmacokinetics and pharmacodynamics of terfenadine and chlorpheniramine in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Cetirizine. A reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Effects of a sedative and of a non-sedative H1-antihistamine on the event-related potential (ERP) in normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Antihistamine effects on the central nervous system, cognitive performance and subjective states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Fexofenadine's effects, alone and with alcohol, on actual driving and psychomotor performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Ebastine: the effect of a new antihistamine on psychomotor performance and autonomic responses in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Effects of mizolastine and clemastine on actual driving and psychomotor performance in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Effects of Fexofenadine, Diphenhydramine, and Alcohol on Driving Performance: A Randomized, Placebo-Controlled Trial in the Iowa Driving Simulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Behavioural effects of histamine and its antagonists: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

The effect of minor tranquilizers on psychomotor performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Sedating drugs and automobile accidents leading to hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

Effect of Promethazine Hydrochloride on Hand–Eye Co-ordination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1077%28200010%2915%3A1%2B%3C%3A%3AAID-HUP247%3E3.0.CO%3B2-S

10.1002/1099-1077(200010)15:1+<::AID-HUP247>3.0.CO;2-S

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12404608